Endovia Health Sciences, Inc.
EDVA- Exchange
- NYSE
- Industry
- Beverages
- SEC CIK
- 0001553788
No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Endovia Health Sciences, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +10 vs. Q4 2021
- Shares held
- 2.81M
- +2.39M (+573.4%) vs. Q4 2021
- Total value
- $7.96M
- +$7.48M (+1,545.2%) vs. Q4 2021
- New holders
- 13
- 6 more added
- Sold out
- 3
- 6 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $172.1K |
| Q1 2026 | 16 | $243.9K |
| Q4 2025 | 14 | $150.7K |
| Q3 2025 | 17 | $255.7K |
| Q2 2025 | 12 | $260.9K |
| Q1 2025 | 11 | $93.4K |
| Q4 2024 | 34 | $720.8K |
| Q3 2024 | 31 | $1.04M |
| Q2 2024 | 32 | $903.3K |
| Q1 2024 | 28 | $1.37M |
| Q4 2023 | 30 | $1.40M |
| Q3 2023 | 28 | $1.61M |
| Q2 2023 | 26 | $2.93M |
| Q1 2023 | 21 | $3.45M |
| Q4 2022 | 24 | $2.19M |
| Q3 2022 | 23 | $2.83M |
| Q2 2022 | 22 | $6.81M |
| Q1 2022 | 25 | $7.96M |
| Q4 2021 | 15 | $484.0K |
| Q3 2021 | 13 | $919.0K |
| Q2 2021 | 9 | $1.01M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Endovia Health Sciences, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,440,700 | $4.09M | 0.00% | +1,426,410+9,981.9% | Added |
| EAM Investors, LLC | 271,808 | $772.0K | 0.14% | +271,808 | New |
| Geode Capital Management, LLC | 209,366 | $594.0K | 0.00% | +197,068+1,602.4% | Added |
| Parsons Capital Management Inc | 133,251 | $378.0K | 0.03% | −10,000−7.0% | Reduced |
| Sabby Management, LLC | 122,698 | $348.0K | 0.15% | +122,698 | New |
| Bridgeway Capital Management, LLC | 115,000 | $327.0K | 0.01% | +115,000 | New |
| Virtu Financial LLC | 91,069 | $259.0K | 0.02% | +91,069 | New |
| Susquehanna International Group, LLP | 87,948 | $250.0K | 0.00% | +87,948 | New |
| Two Sigma Investments, LP | 73,358 | $208.0K | 0.00% | +73,358 | New |
| State Street Corp | 70,000 | $199.0K | 0.00% | +36,300+107.7% | Added |
| Marshall Wace, LLP | 51,005 | $144.0K | 0.00% | +51,005 | New |
| Verition Fund Management LLC | 30,000 | $85.0K | 0.00% | −20,000−40.0% | Reduced |
| Northern Trust Corp | 29,043 | $82.0K | 0.00% | +191+0.7% | Added |
| HB Wealth Management, LLC | 22,430 | $64.0K | 0.00% | +22,430 | New |
| RSM US Wealth Management LLC | 16,064 | $46.0K | 0.00% | +16,064 | New |
| Bank of New York Mellon Corp | 11,709 | $33.0K | 0.00% | +11,709 | New |
| Bank of Montreal | 10,630 | $28.0K | 0.00% | −3,000−22.0% | Reduced |
| Morgan Stanley | 9,205 | $26.0K | 0.00% | −3,016−24.7% | Reduced |
| Tower Research Capital LLC (TRC) | 8,826 | $25.0K | 0.00% | +1,005+12.9% | Added |
| Royal Bank of Canada | 925 | $3.00K | 0.00% | +925 | New |
| Citigroup Inc | 500 | $1.00K | 0.00% | +500 | New |
| UBS Group AG | 110 | $0 | 0.00% | −11,126−99.0% | Reduced |
| Bank of America Corp | 1 | $0 | 0.00% | −57−98.3% | Reduced |
| Wells Fargo & Company | 130 | $0 | 0.00% | +8+6.6% | Added |
| Ionic Capital Management LLC | 100 | $0 | 0.00% | +100 | New |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −58,873−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −16,353−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −13,952−100.0% | Sold out |